newsfilter
← Interviews
Goldman Sachs11 min

Biotech and the Transition from Pandemic to Endemic

Chris Shibutani, Liz

Interview, Fireside Chat

The event analyzes the global transition toward an endemic phase for COVID-19, highlighting a significant disparity where Western nations with high immunization rates differ from the majority of countries in Africa, Asia, and Latin America that remain in the pandemic stage. Industry leaders at BioNTech, Pfizer, and Moderna are currently developing multivalent mRNA vaccines to merge seasonal flu and coronavirus protection, shifting strategies toward frequent boosters to manage waning immunity. The discussion underscores the unprecedented speed of regulatory transparency and clinical development achieved last year while warning against complacency as the world prepares for future pandemic threats.